Paige Prostate
FDA-cleared AI for digital pathology and oncology.
The first FDA-authorized AI system for pathology. It assists pathologists in identifying and segmenting cancerous tissue in prostate biopsies, helping to ensure small foci of cancer are not missed during diagnostic review.
PROS
- + First FDA-authorized AI system for pathology
- + High diagnostic accuracy with up to 99% sensitivity
- + Improves pathologist productivity via case prescreening
- + Standardizes tumor grading (Gleason score) for consistency
- + Seamlessly integrates with existing digital pathology systems
CONS
- - Requires significant upfront investment in digital pathology infrastructure (scanners
- - IT)
- - Custom enterprise pricing model makes it inaccessible for smaller labs
- - Requires the added workflow step of digitizing slides into Whole-Slide Images (WSIs)
-
Detecting prostate cancer in whole-slide images
-
Automating Gleason pattern grading and tumor quantification
-
Prescreening and prioritizing high-suspicion pathology cases
-
Identifying perineural invasion (PNI) for prognosis
-
Providing a quality assurance second read for missed foci
SIMILAR TOOLS
Claude Healthcare
Claude helps healthcare organizations move faster without sacrificing accuracy, safety, or compliance. Less administrative work, more time with the people you serve.
ChatGPT Health
A dedicated experience in ChatGPT designed for health and wellness.
Verily
Precision health platform for research and patient care.
Medtronic (AI Surgery & Diabetes)
AI integrated into surgical robotics and chronic disease.